Literature DB >> 7251161

Neuraminidase activity of Pasteurella haemolytica isolates.

G H Frank, L B Tabatabai.   

Abstract

Neuraminidase activities of Pasteurella haemolytica cell suspensions were measured. Type isolates of the 12 established serotypes and bovine and ovine field isolates were included in the study. Neuraminidase activities ranged from 0 to 0.87 U per mg (dry weight) of P. haemolytica. Activity levels among the isolates studied were serotype associated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251161      PMCID: PMC351567          DOI: 10.1128/iai.32.3.1119-1122.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Serological types of Pasteurella hemolytica.

Authors:  E L BIBERSTEIN; M GILLS; H KNIGHT
Journal:  Cornell Vet       Date:  1960-07

2.  Neuraminidase of Pasteurella multocida.

Authors:  W Scharmann; R Drzeniek; H Blobel
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

3.  [Michaelis constants of neuraminidases of pathogenic and apathogenic microorganisms (author's transl)].

Authors:  H E Müller; H von Nicolai; F Zilliken
Journal:  Z Naturforsch C Biosci       Date:  1975 May-Jun

4.  Pasteurella haemolytica and respiratory disease in cattle.

Authors:  G H Frank
Journal:  Proc Annu Meet U S Anim Health Assoc       Date:  1979

Review 5.  Microbial surfaces in relation to pathogenicity.

Authors:  H Smith
Journal:  Bacteriol Rev       Date:  1977-06

6.  Rapid plate agglutination procedure for serotyping Pasteurella haemolytica.

Authors:  G H Frank; G E Wessman
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

7.  Epidemiological studies on Pasteurella Haemolytica in sheep.

Authors:  E L Biberstein; D A Thompson
Journal:  J Comp Pathol       Date:  1966-01       Impact factor: 1.311

8.  Susceptibility of mice, guinea pigs and hamsters to challenge with Pasteurella hemolytica and its enhancement by microbial polysaccharides and related compounds.

Authors:  G E Wessman
Journal:  J Infect Dis       Date:  1967-12       Impact factor: 5.226

9.  Serotypes of Pasteurella haemolytica in ovine pasteurellosis.

Authors:  D A Thompson; J Fraser; N J Gilmour
Journal:  Res Vet Sci       Date:  1977-01       Impact factor: 2.534

10.  Serological groups among untypable bovine isolates of Pasteurella haemolytica.

Authors:  G H Frank
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

View more
  16 in total

1.  Proteolysis of sialoglycoprotein by Pasteurella haemolytica cytotoxic culture supernatant.

Authors:  G L Otulakowski; P E Shewen; A E Udoh; A Mellors; B N Wilkie
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

2.  Evidence of bovine immunoglobulin G1 (IgG1) protease activity in partially purified culture supernate of Pasteurella haemolytica A1.

Authors:  C W Lee; P E Shewen
Journal:  Can J Vet Res       Date:  1996-04       Impact factor: 1.310

3.  Regulation of expression of the Pasteurella haemolytica leukotoxin determinant.

Authors:  C A Strathdee; R Y Lo
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

4.  Molecular studies of Ssa1, a serotype-specific antigen of Pasteurella haemolytica A1.

Authors:  R Y Lo; C A Strathdee; P E Shewen; B J Cooney
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

5.  Characterization of neuraminidases produced by various serotypes of Pasteurella haemolytica.

Authors:  D C Straus; W L Jolley; C W Purdy
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  Cloning, nucleotide sequence, and expression of the Pasteurella haemolytica A1 glycoprotease gene.

Authors:  K M Abdullah; R Y Lo; A Mellors
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

7.  Effects of Pasteurella haemolytica culture supernate on bovine tracheal smooth muscle.

Authors:  A Bélanger; W H Harris; S Yamashiro
Journal:  Can J Vet Res       Date:  1993-07       Impact factor: 1.310

8.  In vivo production of neuraminidase by Pasteurella haemolytica A1 in goats after transthoracic challenge.

Authors:  D C Straus; C W Purdy
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1.

Authors:  J A Conlon; P E Shewen; R Y Lo
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

10.  Neuraminidase production by a Pasteurella haemolytica A1 strain associated with bovine pneumonia.

Authors:  D C Straus; P J Unbehagen; C W Purdy
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.